Candel Therapeutics (CADL) Current Leases (2022 - 2025)
Candel Therapeutics recorded quarterly Current Leases of $445000.0 in Q4 2025, up 1.83% quarter-over-quarter from $437000.0 in Q3 2025, and down 21.38% year-over-year from $566000.0 in Q4 2024.
Candel Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $445000.0 for Q4 2025.
- In Q4 2025, Current Leases fell 21.38% year-over-year to $445000.0; the TTM figure through Dec 2025 stood at $445000.0 (down 21.38% YoY), while the FY2025 annual figure was $445000.0, down 21.38% from the prior year.
- Current Leases came in at $445000.0 for Q4 2025 at Candel Therapeutics, up from $437000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $594000.0 in Q2 2025 to a low of $429000.0 in Q1 2022.
- A 4-year average of $500062.5 and a median of $494000.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases grew 10.96% in 2023 and dropped 21.38% in 2025, its largest moves.
- Candel Therapeutics' Current Leases stood at $464000.0 in 2022, then grew by 10.56% to $513000.0 in 2023, then rose by 10.33% to $566000.0 in 2024, then slipped by 21.38% to $445000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $445000.0, $437000.0, and $594000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | 445,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 580,000.00 |
| Dec 31, 2024 | 566,000.00 |
| Sep 30, 2024 | 552,000.00 |
| Jun 30, 2024 | 539,000.00 |
| Mar 31, 2024 | 526,000.00 |
| Dec 31, 2023 | 513,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 488,000.00 |
| Mar 31, 2023 | 476,000.00 |
| Dec 31, 2022 | 464,000.00 |
| Sep 30, 2022 | 452,000.00 |
| Jun 30, 2022 | 440,000.00 |
| Mar 31, 2022 | 429,000.00 |